Contact this trialFirst, we need to learn more about you.
Monoclonal Antibodies
Atezolizumab + Chemotherapy for Neuroendocrine Carcinoma
Recruiting1 awardPhase 2 & 3
Baton Rouge, Louisiana
This trial is comparing the effect of immunotherapy with atezolizumab in combination with standard chemotherapy versus standard therapy alone for the treatment of poorly differentiated extrapulmonary small cell neuroendocrine cancer.
Fill-in a few details and create your profileHaving a profile will help us send you recommended trials and speed up your application in the future.
We will keep your details privateWe won’t share unless you give us permission. By completing this form you agree to our privacy policy
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.